Drug
LY3372689
LY3372689 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Phase Distribution
Ph phase_2
1
20%
Ph phase_1
4
80%
Phase Distribution
4
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
4(80.0%)
Phase 2Efficacy & side effects
1(20.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 14 (80.0%)
Phase 21 (20.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease
NCT05063539
completedphase_1
A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants
NCT04392271
completedphase_1
A Safety Study of LY3372689 in Healthy Participants
NCT04106206
completedphase_1
A Study of the Effects of LY3372689 on the Brain in Healthy Participants
NCT03944031
completedphase_1
A Safety Study of LY3372689 Given By Mouth to Healthy Participants
NCT03819270
Clinical Trials (5)
Showing 5 of 5 trials
NCT05063539Phase 2
A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease
NCT04392271Phase 1
A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants
NCT04106206Phase 1
A Safety Study of LY3372689 in Healthy Participants
NCT03944031Phase 1
A Study of the Effects of LY3372689 on the Brain in Healthy Participants
NCT03819270Phase 1
A Safety Study of LY3372689 Given By Mouth to Healthy Participants
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5